CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Calcutta National Medical College, Kolkata, India.
Parkinsonism Relat Disord. 2014 Jan;20(1):75-81. doi: 10.1016/j.parkreldis.2013.09.021. Epub 2013 Sep 25.
Wilson disease (WD) is caused by defects in ATP7B gene due to impairment of normal function of the copper transporting P-type ATPase. This study describes a comprehensive genetic analysis of 199 Indian WD patients including mutations detected in our previous studies, undertakes functional assessment of the nucleotide variants in ATP7B promoter and correlates genotype with disease phenotype. The patient cohort harbors a total of 10 common and 48 rare mutations in the coding region of ATP7B including 21 novel changes. The common mutations represent 74% of characterized coding mutant alleles with p.C271X (63/260) and p.G1101R (7/31) being the most prevalent in eastern and western Indian patients, respectively. The mutation spectrum between east and west is mostly different with only three mutations (p.G1061E, p.N1270S and p.A1049A-fs) being shared between both the groups. Eight novel and 10 reported variants have been detected in the promoter and non-coding regions (5' and 3'UTRs) of ATP7B. Promoter reporter assay demonstrated that 3 novel variants and 5 reported polymorphisms alter the gene expression to a considerable extent; hence might play important role in ATP7B gene regulation. We devised the neurological involvement score to capture the spectrum of neurological involvement in WD patients. By utilizing the age at onset, neurological involvement score and ATP7B mutation background, we generated a genotype-phenotype matrix that could be effectively used to depict the phenotypic spectra of WD affected individuals and serve as a platform to identify prospective "outliers" to be investigated for their remarkable phenotypic divergence.
威尔逊病(WD)是由 ATP7B 基因缺陷引起的,导致铜转运 P 型 ATP 酶的正常功能受损。本研究对 199 例印度 WD 患者进行了全面的基因分析,包括我们以前研究中检测到的突变,并对 ATP7B 启动子中的核苷酸变异进行了功能评估,并将基因型与疾病表型相关联。该患者队列在 ATP7B 编码区共携带 10 个常见和 48 个罕见突变,包括 21 个新变化。常见突变代表了 74%的特征编码突变等位基因,其中 p.C271X(63/260)和 p.G1101R(7/31)在东部和西部印度患者中最为常见。东部和西部的突变谱大多不同,只有 3 个突变(p.G1061E、p.N1270S 和 p.A1049A-fs)在两组之间共享。在 ATP7B 的启动子和非编码区(5'和 3'UTR)中检测到 8 个新的和 10 个报道的变体。启动子报告基因检测表明,3 个新变体和 5 个报道的多态性在相当大的程度上改变了基因表达;因此可能在 ATP7B 基因调控中发挥重要作用。我们设计了神经受累评分来捕捉 WD 患者神经受累的范围。通过利用发病年龄、神经受累评分和 ATP7B 突变背景,我们生成了一个基因型-表型矩阵,可以有效地用于描绘 WD 受影响个体的表型谱,并作为一个平台来识别有前途的“异常值”,以调查他们显著的表型差异。